Skip to content

AbCellera Biologics Inc. ABCL Distributions from equity method investments

Distributions from equity method investments at other companies

Cabot Corporation logo
Cabot CorporationCBT
$1M-91.7%
HES
Hess MidstreamHESM
$4.7M-4.1%
Atmus Filtration Technologies logo
Atmus Filtration TechnologiesATMU
$6M+216%
EPR Properties logo
EPR PropertiesEPR
$0-100%
Nexstar Media Group, Inc. logo
Nexstar Media Group, Inc.NXST
$84M-26.3%
Dolby Laboratories, Inc. logo
Dolby Laboratories, Inc.DLB
$5.28M+479%

Other financials

Income statement

See full
Revenue$8.3M+96.3%
Operating income-$57.5M+8.2%
Net income-$43.2M+5.4%
EPS (diluted)-$0.14+6.7%

Balance sheet

See full
Cash & equivalents$102.1M-44.6%
Total debt$140.2M+107%
Total equity$938.1M-8.3%
Total assets$1.3B-2.8%

Cash flow

See full
Operating cash flow-$33.5M-190%
CapEx$3.8M-64.0%
Free cash flow-$37.4M-68.3%

Valuation

See full
Market cap$1.84B+59.2%
Enterprise value$1.88B+100.0%
P/S23.3×-26.8×

Profitability

See full
Operating margin-267.6%-120pp
Net margin-181.7%-77.9pp
FCF margin-238.9%-90.9pp

Returns & leverage

See full
Return on equity-14.7%-0.8pp
Debt / equity0.1×+0.1×
Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestmentDividendsOrDistributions.

The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s distributions from equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbCellera Biologics Inc.'s distributions from equity method investments?
AbCellera Biologics Inc. (ABCL) reported distributions from equity method investments of $7.53M in Q4 2025.
What does distributions from equity method investments mean?
Cash distributions received from equity method investees as dividend payments or capital returns.